GoodRx (GDRX)
Matches consumers with prescription prices, discounts, subscriptions and manufacturer affordability services.
Something off on this page? Send us feedback.
Helps U.S. consumers compare prescription prices and use savings codes at local and mail-order pharmacies. Transaction fees from PBMs, manufacturers and pharmacies remain the primary engine, alongside subscription and pharma-direct offerings.
Built around free web and app tools, the U.S. marketplace lets consumers compare local and mail-order prescription prices and obtain discounts. The tools serve both insured and uninsured consumers. It earns partner fees when prescriptions are filled using GoodRx codes, while subscriptions and pharma-direct offerings broaden the affordability platform.
A telehealth expansion added online medical visits, prescriptions and lab-test access for routine issues. Prescription transactions remain the business's central revenue source across the United States. Operations depend on relationships with PBMs, manufacturers and pharmacies, while consumer health-information handling is shaped by an FTC privacy-enforcement order.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 20, 2026 | Barclays | Reiterate | Rating: —Target: $3 | Target: $4 |
| Aug 13, 2026 | UBS | Reiterate | Rating: —Target: — | Target: $3.75 |
| Aug 7, 2026 | Goldman Sachs | Reiterate | Rating: —Target: $3.50 | Target: $4 |
| Aug 6, 2026 | Leerink Partners | Target | Target: $3 | Target: $5 |
| May 8, 2026 | Goldman Sachs | Target | Target: $3 | Target: $3.50 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $296.1M · Total debt $539.0M · Total assets $2.34B · Shareholders' equity $647.6M
- Revenue
- $200.4M
- Operating income
- $23.6M
- Net income
- $8.5M
No dividends on record.
| Institutions | 34.98% | 119.32M shares | |
|---|---|---|---|
| 169 holders · as of Jun 30, 2026 | |||
| Insiders | 3.73% | 12.73M shares | |
| 15 holders · as of Sep 15, 2026 | |||
| Strategic holders | 12.78% | 43.60M shares | |
| 2 holders · as of Aug 26, 2026 | |||
| Other | 48.51% | 165.49M shares | |
| remainder | |||
341.15M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Francisco Partners Management, LPInstitution | 17.61% | 60.08M A | as of Jun 30, 2026 |
Idea Men, LLCStrategicdirector, 10 percent owner | 12.65% | 43.16M B | filed Mar 21, 2025 |
Douglas HirschInsider | 2.65% | 9.04M | filed Aug 31, 2023 |
LSV Asset ManagementInstitution | 1.51% | 5.16M A | as of Jun 30, 2026 |
The Bank of Nova ScotiaInstitution | 1.39% | 4.75M | filed Oct 10, 2024 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 26, 2026 | Francisco Partners Iv, L.P. | 10 percent owner | −856,867 | $3.51 |
| Aug 25, 2026 | Francisco Partners Iv, L.P. | 10 percent owner | −127,273 | $3.44 |
| Aug 24, 2026 | Francisco Partners Iv, L.P. | 10 percent owner | −143,594 | $3.46 |
| Aug 21, 2026 | Francisco Partners Iv, L.P. | 10 percent owner | −274,717 | $3.50 |
| Aug 20, 2026 | Francisco Partners Iv, L.P. | 10 percent owner | −447,259 | $3.52 |
- CVS Health
Retail pharmacy and PBM rival in prescription access and savings
- Amazon
Online-pharmacy rival in cash pricing, subscriptions, and delivery
- Cigna
PBM owner with consumer coupons and manufacturer access services
- Walmart
Retail-pharmacy rival in discount prescriptions and convenient delivery
- Hims & Hers Health
Digital-health rival in online consultations and prescription access
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| GoodRx | $3.40 | +0.15% | $1.18B | 79.8 | 10.0 | 1.5 | −1.3% |
| CVS Health | $87.65 | +0.06% | $111.77B | 23.2 | 10.8 | 0.3 | +7.3% |
| Amazon | $254.56 | −1.50% | $2.78T | 20.8 | 27.3 | 3.6 | +19.6% |
| Cigna | $274.39 | −0.03% | $72.53B | 11.4 | 8.7 | 0.3 | +6.6% |
| Walmart | $109.62 | +2.03% | $855.02B | 38.8 | 36.6 | 1.2 | +5.9% |
| Hims & Hers Health | $31.30 | +6.64% | $6.55B | — | 145.6 | 2.5 | +38.3% |
| Median | 22.0 | 27.3 | 1.2 | +7.3% |